Cargando…
Case study: New onset of neuropsychiatric symptoms following switching to a dolutegravir regimen
Although reports of neuropsychiatric side effects have been reported with efavirenz, these have been limited in comparison with regard to the now recommended dolutegravir regimens. We present a patient with new onset neuropsychiatric manifestations secondary to dolutegravir that resulted in signific...
Autores principales: | Badat, Ahmed, Lowton, Karishma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AOSIS
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991107/ https://www.ncbi.nlm.nih.gov/pubmed/35402013 http://dx.doi.org/10.4102/sajpsychiatry.v28i0.1782 |
Ejemplares similares
-
Neurocognitive improvement in HIV-positive patients treated with dolutegravir-based regimens
por: Rodrigues, Janine, et al.
Publicado: (2023) -
Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports
por: Suzuki, Takefumi, et al.
Publicado: (2017) -
First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens
por: Fokam, Joseph, et al.
Publicado: (2020) -
Neuropsychiatric outcomes before and after switching to dolutegravir-based therapy in an acute HIV cohort
por: Chan, Phillip, et al.
Publicado: (2020) -
Assessing the prevalence of psychotic symptoms in epileptic patients at a tertiary clinic
por: Hungwe, Michelle M., et al.
Publicado: (2023)